01 /
Small MoleculesBioTwin small-molecule studies connect pockets, allostery and covalent chemistry to mechanism and exposure questions.
BioTwin / Solution modalities
What if the right solution is a different way to intervene?
Blocking a protein, removing it and reducing its production can require very different development programs. Compare the biological job each approach could do, then see where BioTwin has computational methods, strategy templates or planned coverage.
9 modalitys
No matches yet.
Try another scientific term, or browse all the possibilities.
Molecular interventions
RNA-directed interventions
02 /
Antisense OligonucleotidesBioTwin antisense strategy templates distinguish transcript knockdown from splice correction; sequence, chemistry and delivery remain program requirements.
05 /
mRNAExplore BioTwin’s mRNA research direction: protein supply, target cells, expression duration and the requirements for a future design workflow.
Targeted degradation
03 /
PROTACsExplore BioTwin’s computational E3 recruiter and linker-geometry studies for targeted protein degradation.
Biological molecules
04 /
BiologicsBioTwin strategy modeling for antibodies and protein or enzyme replacement, with related interface and exposure methods.
Genetic interventions
06 /
Gene TherapyGene-addition and replacement strategy templates in BioTwin, connecting function and isoform context to expression and delivery requirements.
07 /
CRISPR & Gene EditingBioTwin’s gene-editing research direction covers causal intervention hypotheses; guide design, off-target analysis and delivery are future workflow requirements.
Cellular interventions
08 /
Cell TherapiesExplore the relationship between BioTwin’s cell-state models and its future cell-therapy direction, including engineering and functional evidence requirements.
Targeted radiation
09 /
RadiopharmaceuticalsBioTwin’s planned radiopharmaceutical coverage: target binding, isotope and chelator selection, distribution and dosimetry requirements.
Start with the change you need in the biology
These nine modality classes organize BioTwin’s solution framework. Current support ranges from selected computational design studies to strategy templates and research directions. Each page makes that scope explicit.
- Small Molecules · Act on the molecular feature that could change the biology. Explore the modality
- Antisense Oligonucleotides · Change the transcript before it becomes the protein. Explore the modality
- PROTACs · Could removing the protein achieve more than blocking it? Explore the modality
- Biologics · Explore recognition, replacement or restoration with a biological molecule. Explore the modality
- mRNA · What if cells could make the protein your program needs? Explore the modality
- Gene Therapy · Explore supplying the function the biology is missing. Explore the modality
- CRISPR & Gene Editing · Ask whether changing the sequence could change the outcome. Explore the modality
- Cell Therapies · What if the intervention is a cell with a different job? Explore the modality
- Radiopharmaceuticals · Explore a targeted radiation strategy within the program's solution space. Explore the modality
Delivery can determine the choice
The same intended effect may need a different approach in a different tissue or compartment. Match delivery questions to the therapeutic format. Small-molecule partitioning, oligonucleotide uptake and vector delivery need different models and evidence.
- Explore exposure and barrier models · See the current computational scope and the measurements a program would need. Mechanistic Barrier and PBPK Modeling
Compare routes around your target
Describe the biological objective and any modality you are considering. We can discuss relevant scientific work and what a focused evaluation or research collaboration would require.
Discuss a focused scientific evaluation
Tell us the target, the constraint and the decision your team needs to make.